Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Claire Trennery"'
Autor:
Helena Bradley, Claire Trennery, Amy M. Jones, Aoife Lydon, Frances White, Rebecca Williams-Hall, Rob Arbuckle, Erin Tomaszewski, Vivian H. Shih, John Haughney, Amanda Eisen, Tonya Winders, Stephen Joel Coons, Sonya Eremenco, the Patient-Reported Outcome Consortium’s Pediatric Asthma Working Group
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-16 (2023)
Abstract Background Pediatric asthma has been identified by regulators, clinicians, clinical trial sponsors, and caregivers as an area in need of novel fit-for-purpose clinical outcome assessments (COAs) developed in accordance with the U.S. Food and
Externí odkaz:
https://doaj.org/article/a06b4cc6786e4c27bb658d71af0d8d5d
Autor:
Adam Gater, Chloe Tolley, Rebecca Williams‐Hall, Claire Trennery, Helena Bradley, Mirko V. Sikirica, Linda Nelsen, Ana R. Sousa, Daniel J. Bratton, Robert Chan, Robyn vonMaltzahn
Publikováno v:
OTO Open, Vol 7, Iss 4, Pp n/a-n/a (2023)
Abstract Objective To date, no patient‐reported outcome measures have been specifically developed to assess pharmacological treatment effect in participants with severe chronic rhinosinusitis (CRS) with recurrent bilateral nasal polyps (NP). These
Externí odkaz:
https://doaj.org/article/a07764f2f4a24a06871016cfabfa7a30
Autor:
Hannah Staunton, Claire Trennery, Rob Arbuckle, Maitea Guridi, Elena Zhuravleva, Pat Furlong, Ryan Fischer, Rebecca Hall
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-16 (2021)
Abstract Background In clinical trials for rare diseases, such as Duchenne muscular dystrophy, clinical outcome assessments (COA) used to assess treatment benefit are often generic and may not be sensitive enough to detect change in specific patient
Externí odkaz:
https://doaj.org/article/416ee6bbd7c444bd92c33fa1ca6a1306
Autor:
Rebecca Williams-Hall, Claire Trennery, Kate Sully, Samantha Wratten, Anya Francis, Dale Chandler, Jessica Flynn, Megan Turner, Daniel J. B. Marks, Alfred Sackeyfio, Marguerite Bracher, Alex Walker, Louise Walker-Nthenda, Rob Arbuckle, Tom Keeley
Publikováno v:
Quality of Life Research. 32:209-223
Purpose To explore symptoms and disease impacts of Crohn’s disease and to develop a new patient-reported outcomes (PRO) measure according to industry best practices. Methods A conceptual model of relevant symptoms experienced by patients with Crohn
Autor:
EMMA C GOODALL, ROBERT WOOD, BEADE NUMBERE, THEO TRITTON, CLAIRE TRENNERY, MARK P SMALL, NATASHA OPPERMANS, ROSIE R WILD, CHRISTOPHER COMPTON, DAVID J SLADE, SHIYUAN ZHANG
Publikováno v:
Chest. 162:A1943-A1944
Autor:
JAEIN SEO, SHIYUAN ZHANG, NICOLAS KRUCIEN, DAVID J SLADE, ALEXANDROSZ CZIRA, CLAIRE TRENNERY, SEBASTIAN HEIDENREICH
Publikováno v:
Chest. 162:A1950-A1951
Autor:
EMMA C GOODALL, ROBERT WOOD, BEADE NUMBERE, THEO TRITTON, CLAIRE TRENNERY, MARK P SMALL, NATASHA OPPERMANS, ROSIE R WILD, CHRISTOPHER COMPTON, DAVID J SLADE, SHIYUAN ZHANG, KIERAN J ROTHNIE
Publikováno v:
Chest. 162:A1941-A1942
Autor:
JAEIN SEO, SHIYUAN ZHANG, DIAN ZHANG, DAVID J SLADE, ALEXANDROSZ CZIRA, CLAIRE TRENNERY, SEBASTIAN HEIDENREICH
Publikováno v:
Chest. 162:A1948-A1949
Autor:
R. Hall, Ryan Fischer, Hannah Staunton, Pat Furlong, Claire Trennery, Maitea Guridi, Elena Zhuravleva, Rob Arbuckle
Publikováno v:
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-16 (2021)
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-16 (2021)
Background In clinical trials for rare diseases, such as Duchenne muscular dystrophy, clinical outcome assessments (COA) used to assess treatment benefit are often generic and may not be sensitive enough to detect change in specific patient populatio
Autor:
Nicola Bonner, Emre Yucel, Alejandro Moreno-Koehler, Kate Sully, Sumeet Panjabi, Andrew Trigg, Nina Shah, Kim Cocks, Claire Trennery
Publikováno v:
European journal of haematology, vol 103, iss 5
European Journal of Haematology
European Journal of Haematology
Objectives Thresholds for the minimally important difference (MID) or responder definition (RD) in health‐related quality‐of‐life (HRQoL) scores are required to interpret the impact of an intervention or change in the trajectory of the conditio